BioKangtai

Forecast & Rating5 analysts currently cover BioKangtai, with about 60.0% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥16.44, about 31.0% upside from the current price of ¥12.55. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 0.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study BioKangtai closely still see room for the stock to rise. Data as of May 26, 2026; for reference only and not investment advice.